Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Experimental Biology and Medicine (Maywood, N.J.)|October 12, 2011
Dendritic cells derived from HOXB4-immortalized hematopoietic bone marrow cellsAbdul Mannan Baru, Jayendra Kumar Krishnaswamy, Anchana Rathinasamy, et al.
Environmental Research|October 25, 2023
Development of aptasensor for chlorpyrifos detection using paper-based screen-printed electrodeJayendra Kumar Himanshu, G B V S Lakshmi, Awadhesh Kumar Verma, et al.
Current Gene Therapy|April 3, 2026
CFTR mRNA-Based Gene Therapy for Cystic Fibrosis: A Mutation-Agnostic Strategy to Restore Ion Transport FunctionJayendra Kumar, Mehetre Dattatraya Martand, Arpan Kumar Tripathi, et al.
AAPS Pharmscitech|August 21, 2025
Stimuli-responsive Hydrogels for Targeted Antibiotic Delivery in Bone Tissue EngineeringJayendra Kumar, Tolepbergenova M, Abdugani Musayev, et al.
Plos One|December 17, 2020
Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterpartsSusan Monkley, Jayendra Kumar Krishnaswamy, Melker Göransson, et al.
American Journal of Respiratory Cell and Molecular Biology|September 11, 2012
Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophiliaJayendra Kumar Krishnaswamy, Adan Chari Jirmo, Abdul Mannan Baru, et al.
Current Medical Science|January 8, 2026
Graphene Quantum Dots in Cancer Diagnostics and Therapeutics: Advances in Biosensing, Imaging, and Treatment ApplicationsManish R Bhise, Vishal Trivedi, Suprabha Devi, et al.
Plos One|October 17, 2012
Absence of Foxp3+ regulatory T cells during allergen provocation does not exacerbate murine allergic airway inflammationAbdul Mannan Baru, Venkateswaran Ganesh, Jayendra Kumar Krishnaswamy, et al.
Assay and Drug Development Technologies|June 12, 2025
Modulation of Anti-Inflammatory Activity via Diclofenac Sodium-Based Nanostructured-Lipid Carriers: Physical Characterization and <i>In Vivo</i> AssessmentAlok Pratap Singh, Dinesh Puri, Iti Chauhan, et al.
European Journal of Immunology|March 10, 2010
The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigensChittappen K Prajeeth, Adan Chari Jirmo, Jayendra Kumar Krishnaswamy, et al.
Pageof 4